Gossamer Bio, Inc. Forecast, price target & analysts
Gossamer Bio, Inc. Target price 2026 - Analyst rating & recommendation
Gossamer Bio, Inc. Classifications & Recommendation
Gossamer Bio, Inc. Price Target
| Target Price | $1.53 |
| Price | $10.94 |
| Deviation |
86.01%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target Gossamer Bio, Inc. 2027 .
The average Gossamer Bio, Inc. target price is $1.53.
This is
86.01%
register free of charge
$9.45
13.62%
register free of charge
$0.28
97.41%
register free of charge
|
|
| A rating was issued by 14 analysts: 9 Analysts recommend Gossamer Bio, Inc. to buy, 4 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Gossamer Bio, Inc. stock has an average upside potential 2027 of
86.01%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 48.47 | 33.71 |
| 57.74% | 30.45% | |
| EBITDA Margin | -336.77% | -292.87% |
| 553.70% | 13.03% | |
| Net Margin | -351.50% | -429.41% |
| 613.19% | 22.17% |
9 Analysts have issued a sales forecast Gossamer Bio, Inc. 2026 . The average Gossamer Bio, Inc. sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Gossamer Bio, Inc. EBITDA forecast 2026. The average Gossamer Bio, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 Gossamer Bio, Inc. Analysts have issued a net profit forecast 2026. The average Gossamer Bio, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.75 | -0.30 |
| 200.00% | 60.00% | |
| P/E | negative | |
| EV/Sales | 1.36 |
9 Analysts have issued a Gossamer Bio, Inc. forecast for earnings per share. The average Gossamer Bio, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Gossamer Bio, Inc....
Current Gossamer Bio, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 21 2026 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Aug 14 2026 |
| Leerink Partners |
Locked
➜
Locked
|
Locked | Jul 28 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jul 27 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jun 25 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 26 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | May 19 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 21 2026 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Aug 14 2026 |
|
Locked
Leerink Partners:
Locked
➜
Locked
|
Jul 28 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jul 27 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jun 25 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 26 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
May 19 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
